Read the latest positive news, breakthroughs, and inspiring stories about pancreatic cancer, curated daily by BrightWire.
A breakthrough oral drug called daraxonrasib has doubled survival times for patients with advanced pancreatic cancer. The historic achievement conquers a stubborn genetic mutation once considered undruggable for over four decades.
Cooking researcher Shim Young-sun was given months to live after a pancreatic cancer diagnosis at 70, but declared fully recovered one year later by focusing on food as healing. Now 89, she still teaches weekly cooking classes and has developed over 5,000 recipes during her 60-year career.
Revolution Medicines is one step closer to bringing a new pancreatic cancer treatment to patients across Europe. The regulatory milestone offers fresh hope for one of the deadliest cancers.
Scientists have developed breakthrough drugs targeting RAS, a gene mutated in one-third of all cancers that experts once thought was impossible to treat. Decades of research funded by the National Cancer Institute are now saving lives with personalized therapies for pancreatic and other cancers.
A routine heart scan revealed pancreatic cancer in a 72-year-old bookstore owner before symptoms appeared. Thanks to early detection and new treatments, Vicky Titcomb is now cancer-free and helping others facing the same battle.
A groundbreaking clinical trial is now recruiting 400 patients to test a promising new drug combination for the most common form of pancreatic cancer. Early results suggest the dual therapy works better than either treatment alone.
Scientists turned an "undruggable" gene into a lifesaving treatment that's now helping patients with two deadly cancers. What started as a lung cancer discovery just transformed pancreatic cancer care.
A University of Toledo scientist just received an $80,000 grant to crack the code on why pancreatic cancer resists treatment. His promising approach targets a protein that helps cancer cells survive and adapt.
Scientists are pioneering a breakthrough strategy to stop pancreatic cancer before it spreads, potentially tripling five-year survival rates from 14% to 50%. A newly approved drug combined with early detection could transform one of the world's deadliest cancers into a manageable disease.
A breakthrough pancreatic cancer drug just earned FDA fast-track status, bringing hope to thousands facing one of the deadliest cancers. Patient advocates are already creating guides to help families understand the new treatment.
A groundbreaking treatment delivers chemotherapy directly to pancreatic tumors instead of flooding the whole body, dramatically reducing nausea, fatigue, and hair loss. Patients are living better lives while fighting one of the toughest cancers to treat.
Scientists have developed a blood test that catches pancreatic cancer in its earliest stages with 87% accuracy, offering hope for a disease that's usually diagnosed too late. The test could save countless lives by detecting the deadly cancer years before symptoms appear.